FBRX Stock Summary and Trading Ideas (Forte Biosciences | NASDAQ:FBRX)

Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).

Forte Biosciences trades on the NASDAQ stock market under the symbol FBRX.

As of January 30, 2026, FBRX stock price climbed to $29.27 with 211,456 million shares trading.

FBRX has a beta of 1.75, meaning it tends to be more sensitive to market movements. FBRX has a correlation of 0.06 to the broad based SPY ETF.

FBRX has a market cap of $366.66 million. This is considered a Small Cap stock.

In the last 3 years, FBRX traded as high as $35.62 and as low as $4.11.

The top ETF exchange traded funds that FBRX belongs to (by Net Assets): VTI, VXF, ATFV, IWC, SBIO.

FBRX has outperformed the market in the last year with a return of +99.8%, while the SPY ETF gained +16.2%. In the last 3 month period, FBRX beat the market returning +103.5%, while SPY returned +1.0%. However, in the most recent 2 weeks FBRX has underperformed the stock market by returning -10.5%, while SPY returned 0.0%.

FBRX support price is $26.37 and resistance is $32.07 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that FBRX shares will trade within this expected range on the day.